A. Menarini to Distribute Credo Diagnostics Coronavirus Assay Kit, Respiratory Infection Assays

Apr 02, 2020

|

NEW YORK – A. Menarini Diagnostics and Credo Diagnostics Biomedical announced on Thursday an exclusive distribution agreement for Credo's SARS-CoV-2 assay kit and other assays for diagnosing respiratory syncytial virus and Group Strep A.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

A. Menarini to Distribute Credo Diagnostics Coronavirus Assay Kit, Respiratory Infection Assays

To read the full story....

Breaking News

CDC Develops Test for Simultaneous Detection of COVID-19, Flu

Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity

Roche Garners FDA Emergency Use Authorization for Elecsys IL-6 Test in COVID-19 Patients

Immunovia Raises $43.0M Through Stock Issuance

Eurofins Technologies Nabs CE Mark for Coronavirus Total Antibody Test

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

What's Popular?

OraSure Technologies Prices $82.5M Stock Offering

FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

Randox Laboratories Invests $33.7M to Increase Coronavirus Testing Capacity

Healgen Gets FDA Emergency Use Authorization for Coronavirus Immunoassay

Guardant Health Prices $315M Public Offering

Sponsorships